Robert Kirkman
2013 - Oncothyreon
In 2013, Robert Kirkman earned a total compensation of $1.4M as Former President, Chief Executive Officer and Director at Oncothyreon, a 52% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $202,704 |
|---|---|
| Option Awards | $756,000 |
| Salary | $422,300 |
| Other | $13,161 |
| Total | $1,394,165 |
Kirkman received $756K in option awards, accounting for 54% of the total pay in 2013.
Kirkman also received $202.7K in non-equity incentive plan, $422.3K in salary and $13.2K in other compensation.
Rankings
In 2013, Robert Kirkman's compensation ranked 5,227th out of 12,286 executives tracked by ExecPay. In other words, Kirkman earned more than 57.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,227 out of 12,286 | 58th |
Division Services | 834 out of 1,938 | 57th |
Major group Engineering, Accounting, Research, Management, And Related Services | 74 out of 184 | 60th |
Industry group Research, Development, And Testing Services | 27 out of 63 | 57th |
Industry Commercial Physical and Biological Research | 27 out of 55 | 51st |
Source: SEC filing on May 6, 2016.
Kirkman's colleagues
We found four more compensation records of executives who worked with Robert Kirkman at Oncothyreon in 2013.